JD Health and Eisai China Establish Joint Venture Jingyi Weixiang in Shanghai's Jing'an District to Address Aging Society Challenges

Shanghai, October 27, 2020 /PRNewswire/ -- On October 27, 2020, JD Health and Eisai China jointly announced the establishment of a joint venture in Jing'an District, Shanghai -- Jingyi Weixiang (Shanghai) Health Industry Development Co., Ltd. (hereinafter referred to as "Jingyi Weixiang"). The new company is committed to building a one-stop service platform addressing the lifestyle and health needs of elderly users. Meanwhile, the People's Government of Jing'an District, Shanghai, JD Health, and Eisai China have also reached a tripartite strategic cooperation agreement.

JD Health Care Establishment Ceremony. From left to right: Xiao Jianbo, General Manager of Internet Healthcare at JD Health; Shin'ya Watanabe, Deputy General Manager, Chief Integrity Officer, and Head of the Management Division at Eisai China; Ye Qiang, Vice Chairman of the Jing'an District Committee of the Chinese People's Political Consultative Conference and Director of the Jing'an District Health Commission; Xin Lijun, Vice President of JD.com and CEO of JD Health; Yu Yong, Secretary of the Jing'an District Committee of the Communist Party of China; Yanhui Feng, Senior Vice President of Eisai Co., Ltd. and President of Eisai China; Zhang Jun, Deputy District Mayor of the Jing'an District People's Government; Jin Enlin, General Manager of the Pharmaceutical Department and Head of Strategy and Investment at JD Health; Zhou Yang, Senior Minister of the Neuroscience Business Unit at Eisai China.

In his address, Mr. Zhang Jun, Deputy District Mayor of the Jing’an District People’s Government in Shanghai, stated that Jing’an District is closely aligning with its “One Axis, Three Belts” development strategy to vigorously promote five key industries: commercial and trade services, financial services, professional services, information services, and cultural creativity. Meanwhile, leveraging the district’s advantages as a hub for leading pharmaceutical companies and its abundant medical resources, Jing’an is actively developing the biopharmaceutical industry to establish a world-class global cluster for biopharmaceuticals. He extended his best wishes for Kylin Health’s establishment in Jing’an District and for the future cooperation among the three parties, while affirming that the Jing’an District Government would provide strong support in policy formulation, standardized management, and resource coordination.

Feng Yanhui, Senior Vice President of Eisai globally and President of Eisai China, stated that Eisai has mature operational service experience in Japan’s elderly care industry and services, such as eldercare and nursing, offering models that can serve as references for the Chinese market. Particularly in the field of Alzheimer’s disease, Eisai boasts over 35 years of drug R&D experience, with more breakthrough products expected to launch in this area in the future, benefiting more patients and their families. With strong support from Jing’an District in Shanghai, Jingyi Weixiang, a joint venture established by Eisai China and JD Health, will be based in Shanghai and operate nationwide to actively address the challenges posed by China’s aging society, jointly contributing to the “Healthy China” initiative.

Xin Lijun, Vice President of JD.com and CEO of JD Health, stated that the establishment of Jingyi Weixiang Company marks the tangible outcome of deepened cooperation among Shanghai’s Jing’an District, Eisai China, and JD Health. By fully integrating Eisai’s accumulated international experience, expertise, and innovative medical solutions across multiple disease areas with JD Health’s advantageous businesses and core competencies—such as its pharmaceutical supply chain and internet healthcare services—the company will provide elderly users with comprehensive, higher-quality online healthcare services.

Signing Ceremony of the Tripartite Strategic Cooperation Agreement. Front row, from left: Zhou Yang, Senior Minister of the Neuroscience Business Division at Eisai China; Long Fang, Director of the Investment Promotion Office of Jing’an District; Jin Enlin, General Manager of the Pharmaceutical Department and Head of Strategy and Investment at JD Health. Back row, from left: Feng Yanhui, Global Senior Vice President of Eisai and President of Eisai China; Yu Yong, Secretary of the Jing’an District Committee of the Communist Party of China in Shanghai; Zhang Jun, Deputy District Mayor of the Jing’an District People’s Government in Shanghai; Xin Lijun, Vice President of JD Group and CEO of JD Health.

Currently, China is on the verge of entering a phase of rapid population aging. This demographic shift has intensified the societal burden, particularly driving prominent demands for healthcare and daily living services. However, the existing elderly care workforce in China is far from adequate to meet the objective needs of the developing elderly care sector. The joint venture JD Yi Wei Xiang, established by JD Health and Eisai China, aims to jointly address this pressing social challenge.

Research reports indicate that the middle-aged and elderly population is gradually integrating into the internet ecosystem, becoming the primary user base for online general health services. Leveraging “Internet+” to adapt healthcare models to aging trends has emerged as a preferred strategy to alleviate the pressure on medical and health services amid population aging. Jingyi Weixiang will fully leverage the respective strengths and resources of JD Health and Eisai China, utilizing “Internet+” to promote the adaptation of healthcare models to aging trends.

Roundtable Session, from left: Moderator; Zhou Yang, Senior Minister of the Neuroscience Business Division at Eisai China; Ye Qiang, Vice Chairman of the CPPCC Jing’an District Committee and Director of the Jing’an District Health Commission; Hong Mingming, Secretary of the Party Working Committee of Jing’an Temple Subdistrict; Xiao Jianbo, General Manager of Internet Healthcare at JD Health

Jingyi HealthFollowing its establishment, Jingyi Weixiang will initially focus on full-course management of Alzheimer’s disease, using neurology as its strategic anchor, and will subsequently expand its business scope to meet the medical, nursing, and elderly care needs of older adults and their families. Based in Jing’an District, Shanghai, and serving the entire country, Jingyi Weixiang aims to provide higher-quality services to China’s 250 million elderly population, striving to build the industry’s first one-stop service platform dedicated to delivering comprehensive medical, health, and lifestyle services for older adults.